Obstetrics & Gynecology

Gynecology for the MCCQE: Bleeding, Contraception, Screening and Pelvic Pain

This page explains how the MCCQE tests gynecology and the Canadian practice points behind the answers, from abnormal uterine bleeding to sexual assault care. Work through the decision tables, five practice questions and flashcards to find the gaps that cost marks.

Most tested
Abnormal and postmenopausal bleeding, contraception and emergency contraception, amenorrhea, PCOS, cervical screening, pelvic pain, PID
Guideline to know
SOGC guidelines (AUB, contraception, menopause, endometriosis); provincial cervical screening programs; PHAC STI guide
Classic trap
Skipping the pregnancy test, or giving estrogen to a patient with a contraindication
Study time
10-12 hours, plus 150 practice questions

What the MCCQE tests in gynecology

Gynecology on the MCCQE is mostly office and emergency department gynecology: what a family physician or emergency physician must handle safely before, or instead of, a referral. The questions span all four dimensions of care. Acute care covers heavy bleeding, ovarian torsion, pelvic inflammatory disease and sexual assault. Chronic care covers fibroids, endometriosis, polycystic ovary syndrome, menopause and incontinence. Health promotion covers contraception, HPV vaccination and cervical and breast screening. Psychosocial care covers sexual health, unplanned pregnancy, intimate partner violence and the emotional impact of infertility and pelvic pain.

Assessment items give you a history and a few results and ask for the most likely diagnosis or the best test. Management items ask for first-line treatment, and the right answer often depends on the patient's age and whether she wants pregnancy now, later or never. Communication and professional behaviour items test consent, confidentiality with adolescents, non-judgmental counselling about contraception and termination, and the duty to report suspected child abuse.

Before you read the options, establish three facts from the stem: is she pregnant, is she stable, and what are her reproductive goals. Most gynecology questions turn on one of them.

  • Pregnancy status, stability and reproductive goals decide most answers
  • Expect office-based decisions: first test, first-line drug, when to refer
  • Counselling and confidentiality items are common and scoreable

Abnormal uterine bleeding, postmenopausal bleeding and amenorrhea

Abnormal uterine bleeding (AUB) is the core gynecology presentation. Start with a pregnancy test and an assessment of stability. Then use the PALM-COEIN system to sort causes into structural (polyp, adenomyosis, leiomyoma, malignancy or hyperplasia) and non-structural (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not yet classified). Basic work-up is CBC and ferritin, TSH when the history suggests it, testing for a bleeding disorder when heavy bleeding started at menarche or there is a personal or family bleeding history, and pelvic ultrasound to look for structural causes.

Endometrial sampling is the decision the MCCQE likes most. Biopsy is indicated in patients aged 40 or older with AUB, and in younger patients with risk factors for endometrial hyperplasia or cancer: obesity, chronic anovulation such as PCOS, unopposed estrogen, tamoxifen, Lynch syndrome or bleeding that persists despite treatment. Postmenopausal bleeding is endometrial cancer until proven otherwise and always needs endometrial assessment, with transvaginal ultrasound and biopsy as the usual tools.

For heavy menstrual bleeding without a structural cause, first-line options are the levonorgestrel IUD, combined hormonal contraception, oral progestins, tranexamic acid and NSAIDs, chosen according to contraceptive needs and contraindications. Acute heavy bleeding in an unstable patient needs resuscitation, then high-dose hormonal therapy or tranexamic acid, and urgent gynecology involvement. Fibroids are treated only when symptomatic; options range from medical therapy to myomectomy (fertility preserved), embolization or hysterectomy.

Amenorrhea work-up begins with a pregnancy test, then TSH, prolactin and FSH. Primary amenorrhea (no menses by age 15, or by 13 without breast development) needs examination for secondary sexual characteristics and an assessment of the uterus. In secondary amenorrhea, think pregnancy, hypothalamic causes (low weight, excessive exercise, stress, eating disorders), hyperprolactinemia, thyroid disease, PCOS and premature ovarian insufficiency (high FSH under age 40). Low energy availability in an athlete is a classic stem that needs attention to bone health and eating behaviour, not just hormones.

  • Pregnancy test first, every time
  • Endometrial biopsy: age 40 or older, or risk factors for hyperplasia
  • Postmenopausal bleeding always needs endometrial assessment

Abnormal uterine bleeding: the decision pathway

  1. 1Pregnancy test and stabilityRule out pregnancy first. If unstable, resuscitate and involve gynecology urgently before anything else.
  2. 2Sort with PALM-COEINStructural causes (polyp, adenomyosis, fibroid, malignancy) versus ovulatory, coagulopathy, endometrial and iatrogenic causes.
  3. 3Basic testsCBC and ferritin; TSH if suggested; bleeding disorder testing when heavy since menarche; pelvic ultrasound for structure.
  4. 4Decide on endometrial biopsyAge 40 or older, or risk factors such as obesity, PCOS, unopposed estrogen, tamoxifen or Lynch syndrome. Always after menopause.
  5. 5Treat to her goalsLNG IUD, combined hormonal contraception, progestins, tranexamic acid or NSAIDs, chosen by contraindications and fertility plans.
  6. 6Escalate if treatment failsRe-evaluate structure and sample the endometrium, then consider ablation, myomectomy, embolization or hysterectomy.
The order the MCCQE expects, from first test to treatment.

Contraception, PCOS, infertility and menopause

Contraception questions test eligibility and effectiveness. Long-acting reversible contraception (the hormonal and copper IUDs and the implant) is the most effective and is suitable for adolescents and nulliparous patients. Estrogen-containing methods are contraindicated with migraine with aura, smoking at age 35 or older, a history of venous thromboembolism or known thrombophilia, uncontrolled hypertension, some forms of liver disease, breast cancer and the first weeks postpartum. When estrogen is contraindicated, offer a progestin-only method or a copper IUD. Emergency contraception, from most to least effective, is the copper IUD (up to 7 days), ulipristal (up to 5 days) and levonorgestrel (most effective in the first 3 days, and less effective with higher body weight). Levonorgestrel is available without prescription in Canada.

Polycystic ovary syndrome is diagnosed with two of three features (irregular or absent ovulation, clinical or biochemical hyperandrogenism, polycystic ovarian morphology) after excluding thyroid disease, hyperprolactinemia and non-classic congenital adrenal hyperplasia. Management follows the patient's goals. For cycle control and hirsutism without a wish for pregnancy, combined hormonal contraception is first line, with endometrial protection as a key reason to treat infrequent periods. For ovulation induction, letrozole is first line. Lifestyle change helps all goals, metformin helps metabolic features, and every patient should be screened for dysglycemia, dyslipidemia, sleep apnea and depression.

Infertility is no pregnancy after 12 months of regular unprotected intercourse, or after 6 months if the patient is 35 or older; evaluate earlier with known risk factors. Investigate both partners together: semen analysis, confirmation of ovulation (cycle history, mid-luteal progesterone), tubal patency (hysterosalpingography or saline sonography) and ovarian reserve. Counsel on folic acid, weight, smoking and alcohol, and refer for fertility care when indicated.

Menopause is a clinical diagnosis after 12 months without menses in a patient over 45; FSH testing is not needed in that group. SOGC guidance supports menopausal hormone therapy as the most effective treatment for vasomotor symptoms in healthy symptomatic patients under 60 or within 10 years of menopause. A patient with a uterus needs a progestogen with estrogen to protect the endometrium, and transdermal estrogen carries a lower VTE risk than oral. Non-hormonal options include SSRIs or SNRIs and gabapentin. Vaginal estrogen treats genitourinary syndrome of menopause with minimal systemic absorption.

Pelvic pain, infections and pelvic floor problems

Acute pelvic pain is an emergency branch: rule out ectopic pregnancy first, then consider ovarian torsion (sudden severe unilateral pain, nausea, an adnexal mass; Doppler flow can be normal, so surgery should not be delayed when suspicion is high), a ruptured or hemorrhagic cyst, pelvic inflammatory disease and non-gynecologic causes such as appendicitis. Chronic pelvic pain with dysmenorrhea, dyspareunia and dyschezia suggests endometriosis. SOGC supports empiric treatment with NSAIDs and hormonal suppression (combined hormonal contraception or a progestin) without first requiring laparoscopy, with surgery for failed medical treatment, infertility or diagnostic uncertainty.

Pelvic inflammatory disease is diagnosed clinically: lower abdominal pain with cervical motion, uterine or adnexal tenderness in a sexually active patient. Treat empirically without waiting for swab results, using a regimen from the Public Health Agency of Canada STI guide (an IM ceftriaxone dose plus 14 days of doxycycline, with metronidazole added in many regimens). Admit for pregnancy, tubo-ovarian abscess, severe illness, failure of oral therapy or uncertain diagnosis. Test for chlamydia, gonorrhea, HIV and syphilis, treat partners, and arrange follow-up.

Vaginitis is tested through the discharge, pH and microscopy. Bacterial vaginosis has a thin grey discharge, fishy odour, pH above 4.5 and clue cells; treat with metronidazole when symptomatic. Candidiasis has a thick white discharge, normal pH and itch; treat with an azole. Trichomoniasis is sexually transmitted, has a frothy discharge and a raised pH, and needs treatment of the patient and partners.

Urinary incontinence and prolapse are chronic care items. Stress incontinence is treated first with pelvic floor muscle training; urgency incontinence with bladder training, fluid and caffeine advice, then an antimuscarinic or a beta-3 agonist (mirabegron, often preferred in older adults to avoid anticholinergic effects). Rule out infection and check for retention. Symptomatic prolapse can be managed with pelvic floor training, a pessary or surgery, depending on symptoms and the patient's wishes.

Gynecology red flags

Red flagPositive hCG with pain or bleedingEctopic pregnancy until proven otherwise: ultrasound and hCG, surgery if unstable.
Red flagSudden one-sided pain with vomitingPossible ovarian torsion: urgent gynecology; normal Doppler flow does not exclude it.
Cancer riskAny postmenopausal bleedingEndometrial assessment with ultrasound and biopsy before treating atrophy.
Red flagHeavy bleeding with hypotensionResuscitate, check hemoglobin and type and screen, then stop bleeding with gynecology.
AdmitPID with fever and an adnexal massPossible tubo-ovarian abscess: admit for IV antibiotics and imaging.
InvestigateRapid virilizationNot typical PCOS: measure androgens and look for an ovarian or adrenal tumour.
Any one of these moves the patient to the urgent branch.

Reading the results: hCG, ultrasound, hormones and swabs

Many gynecology items hand you a result and ask what it means. A quantitative hCG is useful in early pregnancy of unknown location. In a viable intrauterine pregnancy, hCG rises steadily over 48 hours; a slow rise, a plateau or a fall points to a failing pregnancy or an ectopic pregnancy. When the hCG is above the level at which an intrauterine sac should be visible on transvaginal ultrasound and no sac is seen, ectopic pregnancy becomes the leading concern. An unstable patient with a positive pregnancy test and free fluid does not need serial hCG: she needs resuscitation and surgery.

Pelvic ultrasound in abnormal bleeding looks for structural causes such as fibroids and polyps. In postmenopausal bleeding, a thin endometrial lining on transvaginal ultrasound lowers the chance of cancer, but persistent or recurrent bleeding still needs tissue sampling. A complex adnexal mass in a postmenopausal patient needs referral for gynecologic oncology assessment, and CA-125 helps triage a known mass even though it is not a screening test.

Hormone results follow simple patterns. A high FSH with low estradiol in a patient under 40 with amenorrhea, confirmed on repeat testing, suggests premature ovarian insufficiency, which needs hormone replacement until the usual age of menopause to protect bone and heart. A low or normal FSH with low estradiol suggests a hypothalamic cause such as low energy availability. A raised prolactin needs a repeat, a check for drugs such as antipsychotics, thyroid testing and a pregnancy test before pituitary imaging. Raised androgens with rapid virilization, such as voice change or clitoromegaly, are not typical of PCOS and need a search for an androgen-secreting tumour.

Swabs and microscopy matter in vaginitis and STI items. Nucleic acid amplification tests (NAAT) on a vaginal swab, which the patient can often collect herself, or on urine are the standard for chlamydia and gonorrhea. Culture is added for gonorrhea when antimicrobial resistance is a concern or treatment has failed, because culture allows susceptibility testing. A positive gonorrhea or chlamydia result is reportable to public health in Canada, and partner notification is part of management.

  • Slow-rising hCG with no intrauterine sac: think ectopic
  • Thin postmenopausal endometrium does not end the workup if bleeding persists
  • High FSH under 40 on repeat testing: premature ovarian insufficiency
  • Rapid virilization is not PCOS: look for a tumour
  • Chlamydia and gonorrhea are reportable; notify partners

Cervical screening, gynecologic cancers and breast complaints

Cervical screening in Canada is organized by provincial and territorial programs, and the MCCQE expects Canadian logic rather than US start ages. Most programs start screening at age 25 in people who have ever been sexually active, and many have moved or are moving to HPV-based primary screening with longer intervals than cytology. Do not screen adolescents, do not restart routine screening after a hysterectomy for benign disease with no history of high-grade lesions, and stop at the program's upper age after adequate negative results. HPV vaccination is recommended by NACI and offered through school programs; vaccinated people still need screening.

Ovarian cancer has no recommended screening test for average-risk patients: CA-125 and pelvic ultrasound are not screening tools. Refer patients with a strong family history or known BRCA or Lynch variants for genetic counselling. SOGC supports opportunistic salpingectomy at hysterectomy or tubal sterilization to lower the risk of high-grade serous cancer, a practice that was developed in Canada. Endometrial cancer presents with postmenopausal bleeding; vulvar lesions that persist, itch or bleed need biopsy, and lichen sclerosus is treated with a potent topical corticosteroid and followed because of its cancer risk.

Breast complaints are a family medicine favourite. A palpable lump needs imaging even if a recent mammogram was normal: ultrasound in younger patients, diagnostic mammography with ultrasound in older patients, and core biopsy for a suspicious or persistent mass. Unilateral, spontaneous, bloody or single-duct nipple discharge needs imaging and referral. The Canadian Task Force recommends screening mammography every 2 to 3 years from 50 to 74, and several provinces now allow self-referral from age 40; follow the provincial program in the stem.

Sexual assault care and termination of pregnancy

Sexual assault questions test priorities and consent. Treat injuries first, then offer care in steps, getting consent for each one, and let the patient decide whether to report to police; adult sexual assault is not reportable without the patient's consent. If she wants forensic evidence collected, involve the local sexual assault treatment program, which has trained staff and kits, and remember that evidence can be collected and stored even if she has not decided about reporting. Offer emergency contraception, STI prophylaxis, HIV post-exposure prophylaxis when the exposure warrants it (ideally within hours and no later than 72 hours), hepatitis B vaccination and follow-up with counselling. If the patient is a child or adolescent and abuse is suspected, you must report to child protection services.

Termination of pregnancy in Canada is a health service, not a criminal matter, since abortion was removed from the Criminal Code. Options are medication abortion with mifepristone and misoprostol (Health Canada has approved it for use in early pregnancy, prescribed by physicians or nurse practitioners and dispensed by pharmacists) and procedural aspiration. Before medication abortion, confirm gestational age and exclude ectopic pregnancy by ultrasound or clinical assessment and hCG follow-up, check Rh status according to local protocol, and plan follow-up to confirm completion. Counselling is non-directive. A physician with a conscientious objection must not obstruct access, and provincial college policies set expectations for an effective referral.

Communication, consent and ethics in gynecology

Gynecology carries more communication items than most subjects, because the history is intimate and the decisions are personal. Before a pelvic or breast examination, explain what you will do and why, ask for explicit consent, offer a chaperone, and stop if the patient asks. Examinations of an anesthetized patient for teaching are not acceptable without specific prior consent. Use plain words, avoid assumptions about sexual orientation or partners, and ask about sexual history in a routine, non-judgmental way.

Adolescents raise confidentiality questions. A capable adolescent can consent to contraception, STI care and pregnancy care without a parent under the mature minor principle, and that information stays confidential. The limits are risk of serious harm and suspected abuse. Sexual activity involving a young adolescent and a much older partner may meet the threshold for a child protection report, so the exam expects you to know that age-of-consent rules exist under the Criminal Code and to report when abuse is suspected.

Intimate partner violence often appears behind a gynecology complaint: repeated STIs, chronic pelvic pain, unplanned pregnancies, a partner who will not leave the room, or injuries in pregnancy. See the patient alone, ask directly and kindly, assess immediate safety, document carefully and offer local resources. For an adult, reporting to police is her decision, except where provincial law requires a report, for example when children are exposed or at risk.

Two other professional themes recur. Conscientious objection to contraception or abortion must never block access: provincial college policies set out what referral or transfer is expected, and urgent care must be provided regardless. Disclosure applies when something goes wrong, such as a missed abnormal screening result: tell the patient what happened, apologize, arrange follow-up, and report through your institution, with advice from the CMPA if needed.

  • Explicit consent and a chaperone offer before intimate examinations
  • Mature minors can consent; confidentiality has limits for harm and abuse
  • Screen for intimate partner violence with the patient alone
  • Objection must never block access; disclose errors honestly

How the MCCQE frames gynecology: three mini cases

Case 1. A 34-year-old smoker who has migraine with aura asks to restart the combined pill she took in her twenties. The trap is to continue a method she used before. The exam wants you to recognize two strong reasons to avoid estrogen, explain the stroke risk without judgment, and offer a hormonal IUD, an implant, a progestin-only pill or a copper IUD, while also supporting smoking cessation.

Case 2. A 27-year-old with a positive home pregnancy test has mild left lower quadrant pain and light spotting. Vital signs are normal. Transvaginal ultrasound shows no intrauterine pregnancy and no adnexal mass. The best next step is a quantitative hCG with a repeat in 48 hours and clear return advice, not reassurance and not immediate surgery. If she becomes unstable or develops peritoneal signs, the branch changes to emergency surgery.

Case 3. A 47-year-old with heavy, irregular bleeding for eight months has a hemoglobin of 98 g/L and a low ferritin. She has finished having children and wants the bleeding to stop. The scoring answer orders endometrial sampling because of her age, treats the iron deficiency, and offers a levonorgestrel IUD as an effective first-line option before discussing ablation or hysterectomy. Jumping straight to surgery or skipping the biopsy loses the mark.

How gynecology shows up in NAC stations

Gynecology stations at the NAC usually test history, counselling and communication rather than a pelvic examination on a standardized patient. Common tasks are a focused history for abnormal bleeding or amenorrhea, contraception counselling, emergency contraception, menopause symptom counselling, discussing an abnormal cervical screening result, and caring for a patient after sexual assault.

For a bleeding history, cover the pattern (timing, duration, volume, clots, flooding, intermenstrual or postcoital bleeding), last menstrual period and pregnancy possibility, symptoms of anemia, bleeding disorder screening questions, medications including anticoagulants, contraception, sexual history, cervical screening history, weight change and hyperandrogen symptoms. If an examination is asked for, describe it: vital signs, abdominal examination, and that a speculum and bimanual examination would be done with consent and a chaperone.

In counselling stations, the examiner looks for accurate information, a check of contraindications, respect for the patient's choice and a safety plan. Use plain language, check understanding, and close with follow-up. At the oral question signal, expect to be asked for investigations, a first-line treatment or what you would do if the patient were unstable.

  • Bleeding history: pattern, LMP, anemia, bleeding disorder, drugs, screening
  • Describe pelvic examination with consent and chaperone; do not perform it
  • Counselling: contraindications, options, patient choice, follow-up

Canadian differences and how to read gynecology stems

Key Canadian points: cervical screening follows provincial programs and usually starts at 25, levonorgestrel emergency contraception is sold without prescription, mifepristone is prescribed and dispensed from community pharmacies, the mature minor rule allows an adolescent to consent to contraception, STI care and pregnancy care on her own, and STI treatment follows the PHAC guide rather than US guidance. Provincial drug coverage of contraception varies, and some provinces now provide prescription contraception at no cost, so cost questions should not be answered from a US perspective.

When reading a stem, write down age, last menstrual period, pregnancy test result, vital signs, sexual history and reproductive goals. Then look for the decision words: postmenopausal, age 40 or older, migraine with aura, smoker, desire for pregnancy, positive pregnancy test with pain, cervical motion tenderness. 'Next step' usually means the investigation that changes management, such as an endometrial biopsy or pregnancy test. 'Best management' asks for first-line therapy fitted to her goals. 'What would you tell her' wants accurate, non-judgmental counselling that leaves the decision with the patient.

Gynecology: Canadian answer versus common US habit

Canadian practice on the MCCQE

  • Cervical screening usually starts at 25 through provincial programs
  • STI treatment follows the PHAC guide
  • Mifepristone is prescribed and dispensed from community pharmacies
  • Abortion is regulated as health care, not criminal law
  • Some provinces cover prescription contraception at no cost

Common US or other-system habit

  • Cervical screening often starts at 21
  • STI treatment follows CDC guidance
  • Mifepristone access varies with state law
  • Abortion legality depends on the state
  • Cost depends mainly on private insurance
Exam distractors often reflect US schedules or access rules.
Gynecology decision points by presentation
PresentationKey findingMost appropriate action
Heavy bleeding, age 44No pregnancy, irregular heavy mensesEndometrial biopsy plus CBC and ferritin
Postmenopausal bleedingBleeding a year or more after last periodEndometrial assessment: ultrasound and biopsy
Secondary amenorrheaNegative pregnancy testTSH, prolactin, FSH, then targeted work-up
PCOS, wants pregnancyAnovulatory cycles, normal TSH and prolactinLetrozole for ovulation induction
Contraception requestMigraine with auraProgestin-only method or IUD; avoid estrogen
Emergency contraception, day 4Higher body weightCopper IUD as most effective option
Lower abdominal pain, sexually activeCervical motion and adnexal tendernessEmpiric PID treatment per PHAC guide
Sudden unilateral pain and vomitingAdnexal mass, pregnancy test negativeUrgent gynecology for possible torsion
Hot flashes, age 52, uterus presentNo contraindication to hormonesEstrogen with a progestogen, transdermal if VTE risk
Palpable breast lumpRecent normal screening mammogramDiagnostic imaging and biopsy, not reassurance

Worked examples in MCCQE style

Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for gynecology.

Example 1

A 58-year-old woman sees her family physician for two episodes of light vaginal bleeding over the past month. Her last menstrual period was 6 years ago. She has hypertension and type 2 diabetes, and her BMI is 36 kg/m2. She takes no hormone therapy. Pelvic examination shows an atrophic cervix with no visible lesion and a normal-sized uterus. Her last cervical screening test, 2 years ago, was negative.

What is the most appropriate next step?

Show answer and reasoning

Answer: B. Endometrial assessment with biopsy

  • A. Atrophy is a common cause, but postmenopausal bleeding must be investigated for endometrial cancer before attributing it to atrophy.
  • B. Postmenopausal bleeding is endometrial cancer until proven otherwise. With obesity and diabetes adding risk, she needs endometrial assessment, usually biopsy with transvaginal ultrasound.
  • C. Cervical screening detects cervical precancer in asymptomatic patients. It is not the test for postmenopausal bleeding, which comes from the endometrium in most serious cases.
  • D. CA-125 is not a diagnostic test for endometrial cancer, and waiting 3 months delays the diagnosis.
  • E. Any postmenopausal bleeding needs investigation. Waiting for recurrence is not acceptable.

Any postmenopausal bleeding needs endometrial assessment before you treat atrophy or reassure.

Based on: SOGC guidance on abnormal and postmenopausal uterine bleeding

Example 2

A 29-year-old woman has been trying to conceive with her male partner for 14 months. Her periods occur every 45 to 90 days. She has acne and hirsutism. BMI is 31 kg/m2. Pregnancy test is negative, TSH and prolactin are normal, and 17-hydroxyprogesterone is normal. Ultrasound shows multiple small follicles in both ovaries. Her partner's semen analysis is normal and hysterosalpingography shows patent tubes.

What is the most appropriate first-line treatment to help her conceive?

Show answer and reasoning

Answer: D. Letrozole for ovulation induction

  • A. The combined pill controls cycles and hirsutism but prevents pregnancy, so it does not match her goal.
  • B. Metformin helps metabolic features and may improve ovulation slightly, but it is less effective than letrozole for live birth and is not first line alone.
  • C. Ovarian drilling is a second-line option after failed medical ovulation induction.
  • D. She meets criteria for PCOS with anovulatory infertility, normal tubes and a normal semen analysis. Letrozole is the first-line drug for ovulation induction, with lifestyle support for weight.
  • E. IVF is reserved for failure of simpler treatments or other indications. Her tubes and partner's semen are normal.

In PCOS with anovulatory infertility, letrozole is first-line ovulation induction; the pill is for patients not seeking pregnancy.

Based on: International evidence-based PCOS guideline; SOGC guidance on ovulation induction

Example 3

A 22-year-old woman attends a family practice in a province whose cervical screening program starts at age 25. She has been sexually active with two partners over the past 3 years, uses condoms inconsistently and has no symptoms. She received one dose of HPV vaccine in school. She asks for a Pap test because her friends in the United States have had one.

What is the most appropriate course of action?

Show answer and reasoning

Answer: C. Explain the start age; offer STI tests

  • A. Screening before the program start age finds many transient HPV changes that would clear on their own and leads to unnecessary procedures.
  • B. HPV testing in people in their early twenties is often positive from transient infection, so it is not used for screening before the program start age.
  • C. Explain that her province starts screening at 25 and why. Offer chlamydia and gonorrhea testing, discuss contraception and condoms, and check whether she should complete her HPV vaccine series.
  • D. Colposcopy is for abnormal screening results, not a baseline in an asymptomatic person.
  • E. Annual cytology is outdated and not recommended in Canada; it starts too early and too often.

Follow the provincial program: do not screen before the start age, and use the visit for STI testing, contraception and HPV vaccination.

Based on: Provincial cervical screening programs; Canadian Task Force on Preventive Health Care; NACI HPV vaccine statement

Example 4

A 19-year-old woman comes to a walk-in clinic 4 days (about 96 hours) after unprotected intercourse when a condom broke. Her last menstrual period began 13 days ago and her cycles are regular. Her BMI is 34 kg/m2. Urine pregnancy test is negative. She has no history of STIs and no contraindication to any method. She wants the most effective option and would like ongoing contraception.

What is the most appropriate management?

Show answer and reasoning

Answer: A. Insert a copper IUD as soon as possible

  • A. Correct. The copper IUD is the most effective emergency contraception, works up to 7 days after intercourse, is not affected by body weight and gives ongoing contraception.
  • B. Levonorgestrel is least effective at 96 hours and with higher body weight, so it is not the best option here.
  • C. Ulipristal is reasonable within 5 days, but starting a hormonal method the next day can reduce its effect; hormonal contraception should wait several days.
  • D. Both the copper IUD and ulipristal can still be used at 96 hours.
  • E. Waiting misses the window for prevention; a pregnancy test later is follow-up, not the plan.

Emergency contraception ranking: copper IUD (up to 7 days), then ulipristal (up to 5 days), then levonorgestrel, which loses effect with time and higher body weight.

Based on: SOGC Canadian Contraception Consensus; sexandu.ca

Example 5

A 24-year-old woman has 4 days of lower abdominal pain and vaginal discharge. Temperature is 38.1 C, pulse 92/min and blood pressure 118/74 mmHg. She has cervical motion tenderness and bilateral adnexal tenderness. Urine pregnancy test is negative. Transvaginal ultrasound shows no adnexal mass or abscess. She is not vomiting, can take oral medication and will return for review in 72 hours.

What is the most appropriate next step?

Show answer and reasoning

Answer: E. Ceftriaxone IM and 14 days of doxycycline

  • A. PID is treated empirically; delay increases the risk of infertility, ectopic pregnancy and chronic pain.
  • B. She has no abscess, is not pregnant, tolerates oral therapy and is not severely ill, so outpatient treatment is suitable.
  • C. A single dose does not treat PID, which needs a 14-day course covering gonorrhea, chlamydia and anaerobes.
  • D. Metronidazole may be added to PID regimens, but alone it does not cover gonorrhea or chlamydia.
  • E. Correct. Outpatient PID treatment per the PHAC guide is IM ceftriaxone plus 14 days of doxycycline, often with metronidazole, plus STI testing, partner treatment and review.

PID is a clinical diagnosis: treat empirically, test for STIs, treat partners and review in about 72 hours. Admit for pregnancy, abscess, severe illness or failed oral therapy.

Based on: Public Health Agency of Canada, Canadian guidelines on sexually transmitted infections (PID)

Quick recall

Tap a card to turn it over. If you can answer all of them without looking, move on to timed questions.

Where candidates lose marks

  • Missing the pregnancy test

    Bleeding, pain or amenorrhea without a pregnancy test first leads to the wrong branch.

  • Estrogen with a contraindication

    Combined pills for a smoker aged 35 or older or a patient with migraine with aura is a classic wrong answer.

  • Reassuring postmenopausal bleeding

    Treating atrophy or waiting before endometrial assessment misses cancer.

  • US cervical screening ages

    Screening a 21-year-old or doing annual Pap tests follows outdated or US logic, not Canadian programs.

  • Ignoring reproductive goals

    Offering the pill to a patient with PCOS who wants to conceive, or hysterectomy to one who wants children, is wrong.

How to study gynecology

  1. Read the MCC Examination Objectives for vaginal bleeding, amenorrhea, contraception, infertility, pelvic pain, menopause and sexual assault.

  2. Learn the AUB approach with PALM-COEIN and the endometrial biopsy criteria until you can apply them in seconds.

  3. Build a contraception table: effectiveness, estrogen contraindications and emergency contraception options.

  4. Review your provincial cervical and breast screening rules alongside CTFPHC recommendations.

  5. Do 150 gynecology questions in timed blocks and log every missed decision point in one line.

  6. Finish with mixed OB/GYN blocks, focusing on counselling and confidentiality items.

Practise gynecology free

Gynecology: questions candidates ask

What gynecology topics come up most on the MCCQE?

Abnormal and postmenopausal bleeding, contraception and emergency contraception, amenorrhea, PCOS, pelvic pain including PID and ectopic pregnancy, screening and menopause are common because they combine frequent presentations with clear decision points. The MCC does not publish counts by topic.

Which cervical screening rules should I follow for the exam?

Use Canadian logic: provincial programs, usually starting at 25, with many moving to HPV-based primary screening. Avoid US start ages and annual Pap tests, and check the program details in the stem if one is given.

Do I need to know contraceptive brand names?

No. Know the methods, their effectiveness and the contraindications to estrogen. The exam wants you to choose a safe method for the patient in front of you.

How is consent tested in adolescent gynecology?

Under the mature minor principle, an adolescent who understands the treatment and its consequences can consent to contraception, STI care and pregnancy care without a parent. Confidentiality is kept unless there is a risk of serious harm or suspected abuse.

Is termination of pregnancy tested on the MCCQE?

Yes, as counselling and safe care: confirming gestational age, excluding ectopic pregnancy, Rh status, follow-up and non-directive counselling. You also need to know your professional duties if you have a conscientious objection.

How do I approach a positive pregnancy test with pain on the MCCQE?

Check stability first. An unstable patient needs resuscitation and surgery. A stable patient needs transvaginal ultrasound and quantitative hCG, with serial hCG if the location is unknown, plus Rh status and clear return advice.

Are gynecology NAC stations likely to include a pelvic examination?

Stations usually test history, counselling and communication. If an examination is part of the task, describe what you would do, with consent and a chaperone, and what you would look for. Follow the door instructions for the station.

What changed in Canadian cervical screening that I should know?

Many provinces are moving from cytology to HPV-based primary screening with longer intervals, and some offer self-collected HPV tests. Program details differ by province, so learn the principles and follow the program described in the stem.

Practise gynecology until the decisions are automatic

Free account, sample questions with full explanations. Upgrade only if it helps.

Start freeSee plans